DongKoo Bio & Pharma

006620 · KOSDAQ · Health Care · SMALL CAP

Treasury share acquisition via trust: status report

(Treasury share acquisition via trust: status report)· FILED 2026-10-22· RCEPT 20261022000305

About this filing

A progress report on a share buyback carried out through a trust: shares bought so far and the amount spent.

Why companies file it: Buyback trusts report their progress and final results.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-10-22, Treasury share acquisition via trust: status report
SourceDART rcept 20261022000305 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-10-22 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).